Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBA
Clinical trial NCT05297994 · COMPLETED
Trial details
- NCT number
- NCT05297994
- Sponsor
- St. Petersburg Research Institute of Vaccines and Sera
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-24
- Primary completion
- 2016-12-12
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.